Brian Jonas, MD, Discusses FDA Approval of Venclexta® in Combination for the Treatment of Newly Diagnosed AML

| Categories: acute-myeloid-leukemia-condition-center, hematology-oncology, pocn-hem-onc

Brian Jonas, MD, PhD, FACP sat down with DocWire News Discusses FDA Approval of Venclexta® in combination with with azacitidine, or decitabine, or low-dose cytarabine […]